Syschem India Q1 Results: Net loss widens to ₹16.68 lakh
Syschem (India) Ltd posted a Q1FY26 net loss of ₹16.68 lakh, down from a ₹16.74 lakh profit in Q1FY25, as expenses outpaced flat revenue. The Board also forfeited ₹39.17 lakh from lapsed convertible warrants that were not exercised by August 3, 2026.

*this image is generated using AI for illustrative purposes only.
Syschem (India) Limited reported a standalone net loss of ₹16.68 lakh for the quarter ended June 30, 2026, marking a reversal from the ₹16.74 lakh profit recorded in the same period of FY25. Revenue from operations remained largely flat at ₹125.95 lakh, compared to ₹126.76 lakh in Q1FY25. The Board of Directors approved these unaudited financial results on August 04, 2026, alongside the forfeiture of ₹39.17 lakh in upfront consideration linked to lapsed convertible warrants.
The company’s operating performance showed mixed signals. While revenue held steady, expenses increased to ₹127.45 lakh from ₹125.09 lakh in the prior year quarter, resulting in a pre-tax loss of ₹14.52 lakh. This contrasts with a pre-tax profit of ₹16.74 lakh in Q1FY25. The statutory auditor, Stav & Co., issued a limited review report on the financial statements in accordance with Standard on Review Engagement (SRE) 2410 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Financial Performance Overview
The following table highlights the key financial metrics for Syschem (India) Limited for the quarter ended June 30, 2026:
| Metric | Q1FY26 (₹ Lakh) | Q1FY25 (₹ Lakh) | Change |
|---|---|---|---|
| Revenue from Operations | 125.95 | 126.76 | -0.6% |
| Total Income | 125.99 | 126.76 | -0.6% |
| Total Expenses | 127.45 | 125.09 | +1.9% |
| Profit Before Tax | -14.52 | 16.74 | Turned Negative |
| Net Profit/Loss | -16.68 | 16.74 | Turned Negative |
| EPS (Basic/Diluted) | -0.31 | 0.38 | Declined |
Note: Figures are in ₹ Lakh unless otherwise specified.
Warrant Lapse and Forfeiture
In addition to the financial results, the Board addressed the status of convertible warrants allotted on a preferential basis on February 04, 2025. The company had allotted 16.7 million warrants, entitling holders to convert them into equity shares within 18 months. The final date for exercise was August 03, 2026.
As allottees failed to exercise their conversion options within the stipulated period, 3.19 million warrants lapsed. Consequently, the company forfeited the upfront amount of ₹39.17 lakh, which represented 25% of the issue price received at the time of allotment. This forfeiture was disclosed under Regulation 30 of the SEBI (LODR) Regulations, 2015.
What the Numbers Show
The shift from profitability to a net loss in Q1FY26 was driven by an expansion in total expenses rather than a decline in top-line revenue. While gross revenue remained stable year-on-year, total expenses rose by approximately 1.9%, primarily due to higher other expenses and employee benefits. Other income saw a significant increase to ₹4.66 lakh from ₹0.52 lakh in the previous year, but this was insufficient to offset the operational cost pressures. The basic earnings per share fell to -₹0.31 from ₹0.38 in Q1FY25, reflecting the impact of the net loss on shareholder value for the period.
Historical Stock Returns for Syschem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -15.75% | -15.81% | -11.44% | -33.85% | -18.24% | +278.84% |
What specific operational or strategic initiatives will Syschem implement to curb the rising expense trend that outpaced revenue growth in Q1FY26?
How might the forfeiture of ₹39.17 lakh from lapsed convertible warrants impact the company's future capital raising strategies or investor confidence in equity-linked instruments?
Given the flat revenue performance, what are management's projections for top-line growth in the upcoming quarters, and are there new product lines or markets being targeted?


































